Google Gemini Co-Lead Noam Shazeer Leaves for OpenAI Amid AI Talent Race 
Obayashi to Acquire Multiplex in $526M Expansion Deal 
US Raises Concerns Over Possible ASML EUV Machine Transfer to China 
Meta Seeks Legal Shield From Child-Harm Lawsuits Amid KOSA Talks 
China Adds MP Materials, USA Rare Earth to Export Control List Amid Escalating U.S.-China Trade Tensions 
Saudi Aramco Explores Sulphur Business Stake Sale to Raise Billions 
BHP Shares Fall as Jansen Potash Project Costs Surge 
SK Hynix Shares Hit Record High After Shipping Next-Generation HBM4E AI Memory Samples 
SpaceX Stock Slides After IPO Rally as Valuation Concerns Grow 
TD Bank Expands Employee Monitoring Software to Boost Productivity Amid Privacy Concerns 
GM and Lockheed Martin Partner to Strengthen U.S. Defense Manufacturing Capacity 
Chinese Social Media Giant Xiaohongshu Eyes Hong Kong IPO at Over $70 Billion Valuation 
US-Iran De-Escalation Shifts Washington’s Focus to AI Regulation and Crypto Legislation 
Samsung Gains Interest from BYD, Google, AMD as AI Chip Demand Strains TSMC Capacity 
Ukrainian Drone Makers Target Japan and Asia Defense Market 
Hyundai to Acquire SoftBank’s Remaining Boston Dynamics Stake for $325 Million 
WINTER SPRINGS, Fla., Jan. 22, 2016 -- IRADIMED CORPORATION (NASDAQ:IRMD) announced today that the Company will release its 2015 fourth quarter financial results before the market opens on Friday, February 5th. IRADIMED management will host a conference call the same day beginning at 11:00 a.m. Eastern Time to discuss those results and to answer questions.
Individuals interested in listening to the conference call may do so by dialing 1-844-413-1781 for domestic callers, or 1-716-247-5767 for international callers, and entering reservation code 37106645.
The conference call will also be available real-time via the Internet at www.iradimed.com/en-us/investors/index.php and selecting Events & Presentations. A recording of the call will be available on the Company’s website for 90 days following completion of the call.
About IRADIMED CORPORATION
IRADIMED CORPORATION is the only known provider of non-magnetic intravenous (“IV”) infusion pump systems that are specifically designed to be safe for use during magnetic resonance imaging (“MRI”) procedures. We were the first to develop an infusion delivery system that neutralizes the dangers and problems present during MRI procedures. Standard infusion pumps contain magnetic and electronic components which can create radio frequency (“RF”) interference and are dangerous to operate in the presence of the powerful magnet that drives an MRI system. Our MRidium MRI compatible IV infusion pump system has been designed with a patented non-magnetic ultrasonic motor, uniquely-designed non-ferrous parts and other special features in order to safely and predictably deliver anesthesia and other IV fluids during various MRI procedures. Our pump solution provides a seamless approach that enables accurate, safe and dependable fluid delivery before, during and after an MRI scan, which is important to critically-ill patients who cannot be removed from their vital medications, and children and infants who must generally be sedated in order to remain immobile during an MRI scan.
Media Contact: Chris Scott Chief Financial Officer IRADIMED CORPORATION (407) 677-8022 [email protected]
